aDepartment of Health Science, Shiga University of Medical Science, Otsu, Japan
bTohoku University 21st Century COE Program ‘Comprehensive Research and Education Center for Planning of Drug Development and Clinical Evaluation’, Japan
cDepartment of Planning for Drug Development and Clinical Evaluation, Japan
dDepartment of Clinical Pharmacology and Therapeutics, Japan
eDepartment of Medical Genetics, Japan
fDepartment of Environmental Health Sciences, Tohoku University Graduate School of Pharmaceutical Sciences and Medicine, Sendai, Japan
gOhasama Hospital, Iwate, Japan
Received 30 January, 2008
Revised 27 March, 2008
Accepted 8 April, 2008
Correspondence to Takayoshi Ohkubo, MD, PhD, Department of Planning for Drug Development and Clinical Evaluation, Tohoku University Graduate School of Pharmaceutical Sciences and Medicine, Tohoku University Hospital, Sendai 980-8574, Japan Tel: +81 22 717 8590; fax: +81 22 717 8591; e-mail: [email protected]